Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eastern European countries
Background: Patients with ankylosing spondylitis (AS) are substantial users of healthcare resources due to chronic and potentially disabling disease. This study assessed the impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with AS in five Central...
Saved in:
Main Authors: | Daniela Opris-Belinski (Author), Shandor F Erdes (Author), Simeon Grazio (Author), Ladislav Šenolt (Author), Maja Hojnik (Author), Orsolya Nagy (Author), Diana Marina (Author), Sándor Szántó (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EXPERIENCE OF TREATMENT OF JUVENILE ANKYLOSING SPONDYLITIS WITH EYES LESION WITH ADALIMUMAB
by: E.I. Alexeeva, et al.
Published: (2009) -
EXPERIENCE OF ADALIMUMAB TREATMENT IN PATIENT WITH JUVENILE ANKYLOSING SPONDYLITIS AND UVEITIS
by: E. V. Mitenko, et al.
Published: (2012) -
EXPERIENCE OF TREATMENT OF JUVENILE ANKYLOSING SPONDYLITIS WITH EYES LESION WITH ADALIMUMAB
by: E.I. Alexeeva, et al.
Published: (2009) -
Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab
by: M. Fernandes, et al.
Published: (2011) -
Early Adalimumab and Anti‐Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients
by: Xiaoliang Ding, et al.
Published: (2020)